CJC-1295 (Without DAC) + Ipamorelin is a research peptide combination studied for its role in coordinated growth hormone–related signaling. This blend pairs a short-acting growth hormone–releasing hormone (GHRH) analog with a selective growth hormone secretagogue, making it a common focus in endocrine and metabolic research models.
In laboratory settings, this combination is commonly studied for its involvement in:
Growth hormone release and signaling pathways
Endocrine and pituitary-related research
Metabolic and nutrient utilization signaling
Recovery-focused cellular communication
Circadian and pulse-based hormone activity
Researchers utilize this combination to gain a deeper understanding of how complementary peptide signaling affects hormone dynamics, metabolic regulation, and recovery-related pathways under controlled laboratory conditions.
For laboratory research use only. Not for human consumption.
Reviews
There are no reviews yet.